Clinical Trial Update: Placebo-Controlled Study of Perifosine + Single Agent Chemotherapy for Metastatic Cancer Patients [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled trial evaluating perifosine in combination with a single-agent chemotherapy for metastatic colon cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer

Drugs mentioned

• Perifosine (perifosine)

Snippet

Sponsor: AEterna Zentaris | Conditions: Colon Cancer | Phase 2 | Status: COMPLETED